Sen. Kennedy Warns Against Picking FDA Commissioner From Industry
This article was originally published in The Tan Sheet
Executive Summary
The key attributes for the next FDA commissioner - from Sen. Edward Kennedy's point of view - appear to lend support to the candidacy of Harvard Medical School dermatology lecturer Lynn Drake, MD.
You may also be interested in...
Kerry Could Look To Kessler To Help Tap FDA Head; Wood A Possibility?
Former FDA Commissioner David Kessler may figure prominently in the selection of a new commissioner in the event that a Kerry administration takes over the White House in November
FDA Bypass Budget Authority Being Considered By Sens. Hatch, Harkin
A proposal that would allow FDA to submit its budget requests directly to the congressional panels responsible for funding the agency is being explored by Senators Orrin Hatch (R-Utah) and Tom Harkin (D-Iowa)
FDA "Approvables" Could Be Crawford's First Approval Challenge At FDA
FDA's backlog of 51 pending "approvable" NDAs and supplemental NDAs will provide one quantifiable marker to use in measuring the impact of a commissioner appointment.